Protective effect of complement factor B and complement component 2 variants in age-related macular degeneration
- PMID: 17576744
- DOI: 10.1093/hmg/ddm146
Protective effect of complement factor B and complement component 2 variants in age-related macular degeneration
Abstract
Age-related macular degeneration (AMD) is a devastating disorder of the central retina, causing significant visual impairment for 7.5 million elderly Americans. Abnormal regulation of the complement system likely caused by the Y402H polymorphism in the complement factor H gene is a recognized risk factor for AMD, as is the A69S variant in the poorly characterized LOC387715 gene. Recently, polymorphisms in the factor B (CFB) and complement component 2 (CC2) genes were associated with decreased susceptibility to AMD. To validate this association in independent family-based and case-control Caucasian data sets, we genotyped two single-nucleotide polymorphisms (SNPs) in CC2 and four SNPs in CFB. The R32Q variant of CFB was significantly associated with protection from AMD in the family-based data set (P = 0.025). Three SNPs in CC2 and CFB were strongly associated with decreased risk of AMD in the case-control data set (CC2 E318D: P = 0.02; CC2 rs547154: P = 9 x 10(-6); and CFB R32Q P = 2 x 10(-5)). The minor alleles at CC2 rs547154 and CFB R32Q are present in 4% of cases versus 10% of controls, and as these SNPs are in strong linkage disequilibrium (r(2)=0.92), these results likely represent the same protective signal. After controlling for age, Y402H, A69S and smoking, the effect of CFB R32Q remained quite strong (OR 0.21, 95% confidence interval 0.11-0.39; P < 10(-4)). Likelihood ratio testing and conditional analyses in the case-control data set suggest that a weaker, independent protective effect exists for CC2 E318D.
Similar articles
-
Significance of C2/CFB variants in age-related macular degeneration and polypoidal choroidal vasculopathy in a Japanese population.Invest Ophthalmol Vis Sci. 2012 Feb 16;53(2):794-8. doi: 10.1167/iovs.11-8468. Invest Ophthalmol Vis Sci. 2012. PMID: 22232432
-
Polymorphisms in C2, CFB and C3 are associated with progression to advanced age related macular degeneration associated with visual loss.J Med Genet. 2009 May;46(5):300-7. doi: 10.1136/jmg.2008.062737. Epub 2008 Nov 17. J Med Genet. 2009. PMID: 19015224
-
Role of RDBP and SKIV2L variants in the major histocompatibility complex class III region in polypoidal choroidal vasculopathy etiology.Ophthalmology. 2009 Aug;116(8):1502-9. doi: 10.1016/j.ophtha.2009.03.004. Epub 2009 Jun 25. Ophthalmology. 2009. PMID: 19556007
-
Age-related macular degeneration: a perspective on genetic studies.Eye (Lond). 2008 Jun;22(6):768-76. doi: 10.1038/sj.eye.6702844. Epub 2007 May 11. Eye (Lond). 2008. PMID: 17491602 Review.
-
CFB/C2 gene polymorphisms and risk of age-related macular degeneration: a systematic review and meta-analysis.Curr Eye Res. 2012 Apr;37(4):259-71. doi: 10.3109/02713683.2011.635401. Curr Eye Res. 2012. PMID: 22440158 Review.
Cited by
-
Complement regulation in the eye: implications for age-related macular degeneration.J Clin Invest. 2024 May 1;134(9):e178296. doi: 10.1172/JCI178296. J Clin Invest. 2024. PMID: 38690727 Free PMC article. Review.
-
CRISPR Manipulation of Age-Related Macular Degeneration Haplotypes in the Complement System: Potential Future Therapeutic Applications/Avenues.Int J Mol Sci. 2024 Jan 30;25(3):1697. doi: 10.3390/ijms25031697. Int J Mol Sci. 2024. PMID: 38338978 Free PMC article. Review.
-
Whole genome sequencing of 4,787 individuals identifies gene-based rare variants in age-related macular degeneration.Hum Mol Genet. 2024 Feb 1;33(4):374-385. doi: 10.1093/hmg/ddad189. Hum Mol Genet. 2024. PMID: 37934784 Free PMC article.
-
Complement inhibitors for age-related macular degeneration.Cochrane Database Syst Rev. 2023 Jun 14;6(6):CD009300. doi: 10.1002/14651858.CD009300.pub3. Cochrane Database Syst Rev. 2023. PMID: 37314061 Free PMC article. Review.
-
Molecular Genetic Mechanisms in Age-Related Macular Degeneration.Genes (Basel). 2022 Jul 12;13(7):1233. doi: 10.3390/genes13071233. Genes (Basel). 2022. PMID: 35886016 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous